Wipro Launches Treasury DNA Decisions and Analytics Platform, powered by BELLIN’s tm5
Wipro Limited (NYSE: WIT, BSE: 507685, NSE: WIPRO), a leading global information technology, consulting and business process services company, today announced the launch of Treasury DNA Decisions and Analytics platform that will digitally enable global treasuries using cloud technologies. Treasury DNA is powered by BELLIN’s tm5, a leading treasury management systems provider.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20161013005986/en/
Treasury DNA is a next generation platform with a comprehensive suite of technology services delivered in a subscription-based model, and is ideal for global treasurers who aspire to be future-ready. The platform aims to transform and enhance treasury processes and operations within an enterprise. It provides real-time, integrated data and actionable treasury insights to power financial decision making.
Treasury DNA’s Global Payments suite is ideal for companies to create a centralized, optimized and simplified set of services to handle the payments processing. The Cash suite is suitable for corporate treasuries looking for solutions to manage global cash positions and liquidity management.
“Global treasuries need to be digitally empowered with sophisticated tools and solutions to enable insights-driven financial decisions. Our partnership with BELLIN enhances the strength of our offerings and capabilities in helping global treasuries be future ready,” said Bhanu Murthy B.M., President and Chief Operating Officer, Wipro Limited .
“Treasury DNA is a fantastic offering as it makes treasury functionalities available worldwide on one single platform. This provides Wipro’s global customers with maximum efficiency and transparency in treasury operations. This customer portfolio opens up entirely new and interesting prospects for BELLIN. We are very proud that Wipro chose our treasury management system tm5 as a base for their Treasury DNA to build upon,” added Martin Bellin, Founder and CEO of BELLIN.
To know more about Treasury DNA, please visit http://www.wipro.com/microsite/treasury-dna/ .
About Wipro Limited
Wipro Limited (NYSE: WIT, BSE: 507685, NSE: WIPRO) is a leading information technology, consulting and business process services company that delivers solutions to enable its clients do business better. Wipro delivers winning business outcomes through its deep industry experience and a 360 degree view of “Business through Technology.” By combining digital strategy, customer centric design, advanced analytics and product engineering approach, Wipro helps its clients create successful and adaptive businesses. A company recognized globally for its comprehensive portfolio of services, strong commitment to sustainability and good corporate citizenship, Wipro has a dedicated workforce of over 170,000, serving clients across 6 continents. For more information, please visit www.wipro.com .
BELLIN is a global leader in providing web-based treasury software and services for multinational corporations. Founded by a treasurer and built on the expertise of over 120 experts, BELLIN has been exceeding expectations since 1998. tm5, awarded best “Treasury Management System” at the Fintech Innovation Awards, serves all corporate treasury functions and provides a groupwide treasury overview, mobile and in real time. BELLIN solutions for liquidity planning and financial risks, global payments, netting and risk management as well as the integrated BELLIN SWIFT Service, SaaS/hosting or Treasury as a Service (TaaS) inspire more than 15,000 companies with 25,000+ users in 150+ countries and counting.
Forward-looking and Cautionary Statements
Certain statements in this release concerning our future growth prospects are forward-looking statements, which involve a number of risks, and uncertainties that could cause actual results to differ materially from those in such forward-looking statements. The risks and uncertainties relating to these statements include, but are not limited to, risks and uncertainties regarding fluctuations in our earnings, revenue and profits, our ability to generate and manage growth, intense competition in IT services, our ability to maintain our cost advantage, wage increases in India, our ability to attract and retain highly skilled professionals, time and cost overruns on fixed-price, fixed-time frame contracts, client concentration, restrictions on immigration, our ability to manage our international operations, reduced demand for technology in our key focus areas, disruptions in telecommunication networks, our ability to successfully complete and integrate potential acquisitions, liability for damages on our service contracts, the success of the companies in which we make strategic investments, withdrawal of fiscal governmental incentives, political instability, war, legal restrictions on raising capital or acquiring companies outside India, unauthorized use of our intellectual property, and general economic conditions affecting our business and industry. Additional risks that could affect our future operating results are more fully described in our filings with the United States Securities and Exchange Commission. These filings are available at www.sec.gov . We may, from time to time, make additional written and oral forward-looking statements, including statements contained in the company’s filings with the Securities and Exchange Commission and our reports to shareholders. We do not undertake to update any forward-looking statement that may be made from time to time by us or on our behalf.
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skriv dig op her og modtag pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Business Wire
AZ-VERSUM-MATERIALS19.4.2018 22:17 | pressemeddelelse
Versum Materials Celebrates the Grand Opening of Its Research and Development Facility in Hometown, PA
PHARNEXT19.4.2018 17:47 | pressemeddelelse
Pharnext to Showcase PLEOTHERAPY™ R&D Platform at the 8th Annual Global Orphan Drug Conference
CA-MASIMO19.4.2018 17:03 | pressemeddelelse
New Study Investigates the Utility of Masimo SpHb® in Post-operative Red Blood Cell (RBC) Transfusion Best Practices
CA-SYNTERACT19.4.2018 16:08 | pressemeddelelse
Synteract Repositions Itself with Centers of Therapeutic Development and Unveils Updated Brand Platform
NEL-ASA19.4.2018 16:02 | pressemeddelelse
Nel ASA: Receives Additional Purchase Order from Nikola
VOITH19.4.2018 15:41 | pressemeddelelse
Voith and Franka Emika Form a Strategic Partnership
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum